Sell Your Home Care Business in Australia (2026): PE Buyers and CGT | CT Acquisitions
Start a Conversation

Sell Your Home Care Business in Australia in 2026: Multiples, ASIC, ATO, Aged Care Reform

Sell Your Home Care Business in Australia in 2026: Multiples, ASIC, ATO, Aged Care Reform

Selling your home care business in Australia in 2026 involves country-specific mechanics that US-focused advisors miss. ASIC transfer notifications, ATO capital gains treatment with small business CGT concessions, and Aged Care Quality and Safety Commission approval transferability all shape both deal structure and after-tax proceeds. Multiples clear 6-12x EBITDA at platform scale where Aged Care Reform 2025+ funding and CHSP/HCP provider status dominate. Named PE-backed acquirers include Estia Health, Regis Aged Care, Bolton Clarke, plus regional consolidators.

Home Health business in Australia

If you operate a home care business in Australia and you have searched “sell my home care business in Australia”, the variables that drive your sale price are Australia-specific in ways the broader category data does not capture. The named PE platforms with active deal posture in Australia in 2026, the EBITDA-tier multiples bands stated in A$ AUD, the jurisdiction-specific tax-arbitrage structuring (which is the single largest after-tax lever any owner has), the regulator transfer procedure under Australian Taxation Office (ATO) and the relevant industry licensing body, and the 2024-2026 dated comparable transactions all reshape the multiple a buyer will pay. This page walks through the Australia valuation framework as home care businesses are actually trading in mid-2026, the named buyers actively acquiring here, and the regulator transfer + tax structuring that determine net-of-tax proceeds.

CT Acquisitions runs sell-side M&A advisory mandates for owners of recurring-services businesses across Australia and the broader English-speaking market. The introductory conversation is confidential and NDA-protected. This page is the localised valuation framework for 🇦🇺 Australia home care sellers, built from named-and-dated 2024-2026 transactional research rather than generic broker-listing rules of thumb.

The Australia home care M&A landscape in 2026

The detailed market sizing, named-buyer table, EBITDA-tier multiples bands, regulator transfer procedure, jurisdiction-specific tax-arbitrage structuring, and 2024-2026 dated comparable transactions for Australia home care are set out below. This section is the core valuation framework — everything else on the page is supporting context.

20. HOME-HEALTH (Australia)

1. Market Size & Structure

The Australian aged care and home care sector is the country’s largest publicly-funded social-care vertical and one of the deepest pools of private capital activity in the Asia-Pacific. Aged Care Residential Services in Australia is sized at A$38.7 billion in revenue for 2026 according to IBISWorld industry tracking, while broader aged care including home-based, community and clinical extensions is estimated at USD 34.4 billion (~A$53 billion at A$1 = USD 0.65) in 2025, projected to reach USD 61.3 billion by 2034 at a 6.43% CAGR per IMARC Group. The Australian Institute of Health and Welfare reports more than 1.3 million Australians received some form of aged care support in 2024-2025, of whom ~845,000 received home-based care via Home Care Packages (HCP) or Commonwealth Home Support Programme (CHSP), and ~245,000 lived in residential care.

The sector splits into four economically distinct sub-verticals:

Residential aged care: largest single revenue pool at A$38.7B. Top 10 providers control ~28% of beds. Opal HealthCare leads with 102 care communities after March 2024 acquisition of BlueCross’s 31 Victorian homes. Estia Health operates 93 homes serving ~9,250 residents as at May 2026 announcement of sale by Bain Capital to Stonepeak and Axight Capital at EV ~A$2.5 billion. Regis Healthcare (ASX: REG) operates 72 aged care homes. Bolton Clarke (Australia’s largest independent NFP) runs 70+ residential homes after December 2021 absorption of Allity’s 43 homes + 3,800 beds. Calvary Health Care completed A$380M takeover of ASX-listed Japara Healthcare in November 2021.

In-home aged care (HCP + CHSP, transitioning to Support at Home programme from 1 November 2025): fastest-growing pool. Bolton Clarke, Silverchain, Australian Unity, BlueCare (UnitingCare Queensland), Anglicare Sydney, Catholic Healthcare, Five Good Friends and KinCare (now Silverchain after 2024 acquisition) anchor segment. Silverchain services ~140,000 clients annually post-KinCare deal. Australian Unity emerged as second-largest after A$285M purchase of myHomecare Group from Quadrant Private Equity, closed 28 March 2024.

NDIS disability care: sits adjacent and partially overlaps. NDIS Quality and Safeguards Commission regulates 19,000+ registered providers across A$48B+ federal NDIS budget for 2025-2026. Supported Independent Living (SIL) and platform providers (Mable Technologies, Hireup, Five Good Friends) face mandatory registration from 1 July 2026.

Palliative and community-based care: dominated by NFPs (HammondCare, Calvary, Silverchain Hospice@Home, Bolton Clarke at Home) with limited PE penetration.

Sector EBITDA margins compressed sharply through 2022-2024 from the 15-28% Fair Work Commission award wage rise staggered across January and October 2025. Residential operator margins now at 7-11% EBITDA per occupied bed-day for top-decile, breakeven or worse for bottom quartile. Home care providers at 6-12% EBITDA margins post-wage-rise.

2. PE Buyer Landscape

Australian aged care has become a thesis-grade vertical after the Royal Commission into Aged Care Quality and Safety (2018-2021) drove sector reform, the Aged Care Act 2024 created regulatory certainty, and the Stonepeak acquisition of Estia Health validated the take-private playbook a second time.

Pacific Equity Partners (PEP) — ~A$14B AUM, most active aged care sponsor. 30 May 2025: PEP finalised acquisition of AMP Capital’s 50% stake in Opal HealthCare, valuing Opal at “significantly more than A$2 billion”. Remaining 50% held by Singaporean conglomerate GK Goh Holdings. PEP separately scouted Quality of Life Services in April 2025.

Bain Capital — acquired Estia Health for A$838M in December 2023 at A$3.39 per share, took private off ASX, exited May 2026 by selling to Stonepeak and Axight Capital at ~A$2.5B EV. Holding-period IRR estimated high-20s to low-30s percent.

Quadrant Private Equity — owned myHomecare 2016 until A$285M exit to Australian Unity March 2024 (~3-4x MOIC). Co-owns Mable Technologies (since 2021) with General Atlantic and Ellerston Capital; Mable raised A$119M across funding rounds.

BGH Capital — Ben Gray, Robin Bishop, Simon Harle vehicle (~A$6B AUM). Credible underbidder on multiple residential aged care processes 2023-2025 but no closed platform deal.

Mercury Capital — holds Green by Nature (landscape services), scouted aged care peripheries.

Adamantem Capital — healthcare-adjacent verticals, no flagship residential aged care position.

Allegro Funds — A$5B AUM special-situations sponsor, most likely buyer of distressed regional residential portfolios as post-Aged-Care-Act-2024 transition rolls forward.

Crescent Capital Partners — historical positions in radiology and specialist clinical services.

Anchorage Capital Partners — operational-turnaround healthcare assets.

KKR Australia — scouted Plena Healthcare in 2023 (1,300+ allied health therapist mobile-services platform). No residential aged care position.

Other: EQT holds minority stake in Five Good Friends (since 2021). TPG separately took strategic growth investor position in Five Good Friends. Stonepeak + Abu Dhabi sovereign-adjacent Axight Capital became Estia Health’s new owner in May 2026 announcement, expected to close late 2026 subject to FIRB and ACQSC approvals.

Buyer universe extends to strategic operators (Bolton Clarke, Calvary, Anglicare, BlueCare), institutional infrastructure capital (IFM Investors, AustralianSuper unlisted property), and selectively offshore healthcare strategics (Korian, Orpea-now-Emeis from Europe have done preliminary diligence but no closed transactions).

3. EBITDA-Tier Multiples Bands

Estia Health pricing benchmark cleanest publicly-observable post-Royal-Commission data point: Bain bought at A$838M December 2023, sold at A$2.5B May 2026 = ~13-15x EV/EBITDA on larger 93-home post-growth platform, against est. 9-10x at Bain’s entry on smaller 73-home base.

Residential aged care (per occupied bed-day economics):

In-home aged care (per HCP/Support at Home recipient):

NDIS disability care:

Palliative and community-based care: 5.5-8.5x EBITDA, capped by clinical-staff scarcity and reimbursement-rate volatility under MBS/PBS framework.

4. Regulator Transfer & Licensing

Aged care providers regulated by three distinct bodies, each with own approval process for change-of-control. Regime materially changed on 1 November 2025 when the Aged Care Act 2024 commenced.

Aged Care Quality and Safety Commission (ACQSC) is residential aged care and in-home aged care regulator. Under Aged Care Act 2024, every provider must be registered with ACQSC across one or more of seven registration categories spanning home care, residential care, restorative care and short-term restorative care. Existing approved providers as at 1 July 2025 deemed registered without going through registration process immediately; providers must transition all existing client agreements to new structure by 30 June 2026. Change of control and material ownership changes trigger notification obligation; ACQSC retains power to suspend or vary registration on character, financial-viability or quality grounds. Quality Standards strengthened, with final version published 6 August 2025, increasing emphasis on dementia care, clinical governance, food and nutrition, person-centred care.

Support at Home programme replaces Home Care Packages from 1 November 2025. Funding model expands from 4 package levels (A$10,931 to A$63,440 p.a.) to 8 classification levels (up to A$78,106 p.a.), with substantially restructured pricing schedule of service items, capped administration fees, and consumer-directed-care payment mechanics. Clients receiving HCP before 12 September 2024 received “no worse off” grandfathering.

NDIS Quality and Safeguards Commission regulates disability providers nationally with NDIS Practice Standards. As of December 2025, Minister announced SIL and platform providers must register from 1 July 2026, closing key compliance loophole.

State-based clinical and health-practitioner regulation continues for clinical aged care services. Each state health department licenses health services facilities, nursing services and ambulance-substitute community paramedicine. TGA regulates medication management.

For commercial acquirers, practical ACQSC approval process for change of control runs ~60-120 days post-signing, with diligence focused on character of acquirer (especially for offshore PE sponsors with no existing Australian operator history), financial viability tests, continuity-of-care for residents and clients.

5. Tax Structuring & Arbitrage

Australian small-business CGT concessions are cornerstone of vendor-tax optimisation for founder-owned aged care and home care exits. Framework comprises four pillars under Division 152 of the ITAA 1997.

Basic eligibility: vendor must satisfy A$2 million aggregated turnover test (including connected entities and affiliates) OR A$6 million MNAV test (counts net value of CGT assets owned by vendor, connected entities and affiliates while excluding family home, superannuation balances and personal-use assets). Asset must be “active asset” used in carrying on business.

Pillar 1: 15-year exemption (Subdivision 152-B) — Vendor has continuously owned asset for 15 years immediately preceding CGT event AND aged 55+ with disposal in connection with retirement: entire capital gain disregarded. Amounts contributed to superannuation from 15-year exemption excluded from non-concessional contributions cap, allowing entire sale proceeds (subject to CGT cap, A$1.78 million for 2025-2026) to be parked in superannuation.

Pillar 2: 50% active asset reduction (Subdivision 152-C) — 50% reduction of capital gain. Applied on top of 50% general CGT discount available for individuals and trusts on assets held >12 months = effective 75% reduction.

Pillar 3: A$500,000 retirement exemption (Subdivision 152-D) — Lifetime A$500K cap of capital gain disregarded if proceeds paid into superannuation (where vendor under 55) or otherwise reserved for retirement.

Pillar 4: Small business rollover (Subdivision 152-E) — Deferral of capital gain by acquiring replacement active asset within 2 years.

50% CGT discount to individuals and trusts (not companies) on assets held >12 months stacks with small business concessions = highly favourable founder economics. Founder selling home care business at A$10M capital gain through trust structure, satisfying A$6M MNAV test, can typically reduce taxable capital gain to under A$1M after stacking 50% general discount, 50% active asset reduction, A$500K retirement exemption.

Aged care-specific structuring: Residential providers typically hold operating business in one entity and real-property freehold in related entity or unit trust. RAD (refundable accommodation deposit) liabilities sit on operating-business balance sheet and must be transferred at completion with no break in resident continuity. Vendor financing of RAD balances, deferred consideration linked to occupancy retention, earn-out structures linked to post-completion ACQSC compliance ratings increasingly common post-Royal-Commission.

Home care transactions typically structured as share-sale with vendor warranties around HCP client portability (now Support at Home), HSU/UWU enterprise-agreement continuation, absence of historical underpayment claims. Asset-deal structures uncommon due to client-relationship novation friction with ACQSC.

6. FIRB + ACCC

FIRB notification thresholds updated effective 1 January 2026:

Healthcare and aged care fall within FIRB framework as sensitive sectors. Stonepeak’s Estia Health acquisition publicly disclosed as conditional on FIRB approval.

For foreign government investors (which includes a number of sovereign wealth funds and pension funds with >20% government ownership), threshold is A$0 and notification mandatory regardless of deal size. Axight Capital’s classification as Abu Dhabi sovereign-adjacent triggers foreign government investor pathway, with expected longer review window of 60-120 days plus potential conditions on board composition and Australian-resident director quorum.

New ACCC mandatory merger control regime commenced 1 January 2026 under Part IVA of Competition and Consumer Act 2010. Notification waivers accepted from 12 January 2026 with application fee of A$8,300 per acquisition. General notification thresholds (June 2025 announcement) require notification where:

New control thresholds + asset thresholds commence 1 April 2026. For aged care, practical consequence: all transactions involving top 10 residential operators or top 5 in-home providers will trigger mandatory notification, with suspensory waiting period until ACCC clears or otherwise grants relief.

Combination of FIRB + ACCC + ACQSC (+ NDIS Commission for disability-overlap transactions) creates four-regulator gauntlet for offshore PE sponsors acquiring scaled aged care platforms, end-to-end timing 120-180 days post-signing typical for major transactions.

7. Recent Transactions (2024-2026)

  1. May 2026: Bain Capital sells Estia Health to Stonepeak and Axight Capital at EV ~A$2.5B. Expected to complete late 2026 subject to FIRB, ACCC and ACQSC approvals. During Bain’s investment period, Estia grew from 73 homes/~6,720 residents to 93 homes/~9,250 residents. Axight Capital is Abu Dhabi-based alternative investor classified as foreign-government-adjacent for FIRB purposes.
  2. 30 May 2025: PEP completes acquisition of AMP Capital’s 50% stake in Opal HealthCare. Reported transaction value of “significantly more than A$2 billion” implied for 100% EV. Remaining 50% continues held by GK Goh Holdings. Opal operates 102 care communities.
  3. April 2025: PEP scouts Quality of Life Services for potential platform or bolt-on transaction in home care. No closed transaction as of mid-2026.
  4. 2024: Silverchain acquires KinCare expanding to every state and ACT, total client base ~140,000 annually.
  5. March 2024: Opal HealthCare acquires BlueCross’s 31 Victorian aged care homes, undisclosed sum.
  6. 28 March 2024: Australian Unity completes myHomecare Group acquisition from Quadrant at A$285M (A$215M upfront + deferred over 18 months). Combined entity serves 50,000+ customers across 6,000 staff.
  7. December 2023: Bain Capital take-private of Estia Health at A$3.39 per share, equity A$838M (A$830M EV at offer date), completed January 2024.
  8. 2023: KKR scouts Plena Healthcare. No closed transaction.
  9. 2021: General Atlantic invests A$100M in Mable Technologies; valuing Mable at est. A$300-400M post-money.
  10. 2021: EQT and TPG take separate strategic growth investor positions in Five Good Friends.
  11. 2021: Calvary Health Care completes A$380M takeover of Japara Healthcare at A$1.40 per share, absorbing 50 aged care homes and 5 retirement villages.
  12. December 2021: Bolton Clarke completes Allity acquisition adding 43 homes/3,800 beds across NSW/VIC/QLD/SA.

Pipeline of expected 2026 transactions: potential exits from Mable Technologies, Five Good Friends, Mercury Capital home-care peripheries, long-tail of single-state operators rolling up into PEP-Opal and Stonepeak-Estia post-completion.

8. State Sub-Markets

NSW: largest state market, ~80,000 residential aged care beds across 950 facilities, ~280,000 home care recipients. Sydney metro accounts for 56% of NSW beds with significant supply constraints and high RAD values (A$700K-A$1.5M for premium metro rooms). HSU NSW/ACT/QLD enterprise bargaining cycles driving above-award wage outcomes. Anglicare Sydney is largest NSW NFP operator. Opal HealthCare and Estia Health have heavy NSW concentration.

Victoria: ~65,000 beds across 800 facilities, ~230,000 home care recipients. Melbourne metro accounts for 64% of VIC beds. Densest concentration of mid-sized NFP operators (BlueCross until March 2024, Mercy Health, Benetas, Bolton Clarke Victorian ops, Catholic Healthcare’s southern arm). UWU dominant union in residential settings.

Queensland: ~50,000 beds across 580 facilities, ~180,000 home care recipients. Highest growth rate of any state, driven by inter-state migration of retirees. BlueCare (UnitingCare Queensland) is largest QLD NFP. Bolton Clarke maintains Brisbane headquarters.

WA: ~22,000 beds across 250 facilities, ~75,000 home care recipients. Silverchain headquartered in WA and was originally WA Silver Chain Nursing Association, dominating state’s home care market. Anglican Diocese of Perth, Brightwater Care Group, Bethanie Group control largest NFP positions in residential.

SA: ~20,000 beds across 230 facilities, ~70,000 home care recipients. Highest concentration of religious-order operators (Resthaven, ECH, Anglican Community Care) and most fragmented small-operator long tail.

Tasmania: smallest state market, ~6,200 beds across 80 facilities, ~22,000 home care recipients. Oldest median resident age in Australia and highest dementia-prevalence rate per capita.

ACT: ~3,400 beds across 36 facilities. Goodwin Aged Care Services and IRT Group operate largest portfolios.

NT: ~1,900 beds with most acute workforce-supply challenges in Australia.

9. Labor / Workforce

Aged care and home care workforce is most acute operational challenge in vertical.

Health Services Union (HSU) — primary aged care union ~80,000 members across NSW/ACT/QLD plus Victorian and SA branches. HSU national president Gerard Hayes drove campaign that resulted in Fair Work Commission Aged Care Work Value Case, awarding personal carers wage increase of 18-28%, home care workers 15-26%, other classifications between 15-28%. Direct care workers received increase in two tranches of 50% each on 1 January 2025 and 1 October 2025. Indirect care workers received full amount on 1 January 2025.

United Workers Union (UWU) — second-largest aged care membership, strong Victorian and SA residential coverage.

Australian Nursing and Midwifery Federation (ANMF) — covers registered and enrolled nurses, ~320,000 members nationally.

Fair Work Commission’s Annual Wage Review effective 1 July 2025 increased modern award minimum wages by 3.5%, layering on top of staged 15-28% Aged Care Work Value Case increases. Cumulative effect on typical residential aged care provider’s wage cost line = 22-35% increase over two-year window from January 2024 to July 2026, materially above Commonwealth’s residential funding-rate increases of 11-14% over same period.

Fair Work Legislation Amendment (Closing Loopholes) Act 2023 introduced “Same Job, Same Pay” provisions effective 15 December 2023, with first regulated labour hire arrangement orders taking effect 1 November 2024. ~7,600+ workers across mining, aviation, railway, meat processing, public administration and warehousing have received Same Job Same Pay orders. For aged care, practical impact is labour hire and agency-nursing arrangements widely used during post-COVID workforce crisis are now subject to host-employer wage parity.

CFMEU administration: Construction, Forestry, Maritime, Mining and Energy Union’s Construction & General Division placed in administration in August 2024.

Workforce supply: Department of Health, Disability and Ageing estimates gap of ~35,000 direct care workers as of 2026, projected to widen to 110,000 by 2030 absent material immigration and training-pipeline interventions. Aged Care Worker visa pathway targets ~12,000 international workers per annum 2025-2027.

10. Working Capital + Asset Considerations

Aged care has most distinctive working-capital and asset-base mechanics of any Australian healthcare vertical.

Refundable Accommodation Deposits (RADs) are defining balance-sheet feature of residential aged care. Interest-free loans paid by residents in lieu of daily accommodation contribution, refundable on resident exit subject to retention rights and prudential limits. National RAD pool sits at ~A$36 billion across sector. Average RAD values range from A$350K in regional non-metro markets to A$1.5M+ for premium Sydney/Melbourne CBD rooms. For PE acquirers, RAD liabilities typically transferred at completion without break in resident continuity, requiring detailed actuarial diligence on RAD-out rates, refund timing, reinvestment yield on RAD pool.

Aged Care Funding Instrument (ACFI) → Australian National Aged Care Classification (AN-ACC): residential aged care funding transitioned October 2022. Acquirers must conduct AN-ACC mix diligence.

Real estate and freehold: typically largest non-RAD balance sheet item. Operators may own freehold (Opal, Bolton Clarke, religious-order NFPs) or lease from REITs (Centuria Healthcare REIT, Healthco Healthcare and Wellness REIT, Charter Hall Long WALE REIT, AustralianSuper Property). Sale-and-leaseback transactions accelerated through 2024-2026 as PE acquirers separate operating businesses from freehold.

Home care working capital dominated by accounts receivable from Services Australia (Commonwealth payments for HCP/CHSP/Support at Home) + consumer co-contribution receivables. Support at Home programme transition from 1 November 2025 created material cash-flow disruption for under-scaled providers.

Sale and leaseback economics: typical metro residential cap rates at 6.0-7.0% net, sub-metro 7.0-8.0%, regional 7.5-9.0%. 2025-2026 interest-rate easing cycle (RBA cash rate cut from 4.35% to 3.85% across 2025, further cuts expected through 2026) has compressed cap rates by 50-75 bps.

Insurance and indemnity: professional indemnity, public liability and worker injury insurance premiums increased 22-38% across 2023-2025 driven by Royal Commission litigation risk. Cyber insurance has become material cost line following Bupa Aged Care and mid-tier providers experiencing ransomware events 2023-2025.

Capex profile: Strengthened Quality Standards effective from 1 November 2025 require material capex on dementia-care specific room modifications, fire safety upgrades and nurse-call infrastructure. Typical capex per resident bed is A$15K-A$45K over 2025-2027 compliance window.

11. Why CT Acquisitions

CT Acquisitions advises owner-operators across Australian aged care, in-home aged care, NDIS disability care and palliative community care on sell-side transactions where founder-economics, regulatory navigation and buyer competitive tension determine outcome.

Firm runs full process from confidential approach through ACQSC and NDIS Commission notification, FIRB and ACCC pre-clearance, Aged Care Act 2024 transition diligence, and tax-optimised structuring under Division 152 small business CGT concessions. CT Acquisitions has direct relationships with PEP, Bain Capital (post-Estia divestment platform), Stonepeak, Quadrant, BGH, Mercury, Allegro, Anchorage and Crescent on PE side, plus strategic acquirer universe spanning Opal, Estia, Bolton Clarke, Calvary, Anglicare, Catholic Healthcare, BlueCare, Silverchain and Australian Unity.

Typical sell-side mandate runs A$5M-A$500M EV, with end-to-end timing of 5-8 months from engagement to completion. CT Acquisitions does not represent buyers in transactions where it has previously represented vendors in same sub-vertical, eliminating conflict of interest broker-style intermediaries cannot avoid.

Positioning thesis: aged care and home care in Australia entering a 5-to-7-year platform-consolidation window driven by Aged Care Act 2024, Support at Home transition, strengthened Quality Standards, persistent workforce-cost pressure from Fair Work Commission decisions, and convergence of PE capital with strategic operator demand. Transactions that closed 2024-2026 (Estia to Stonepeak, Opal 50% to PEP, myHomecare to Australian Unity, KinCare to Silverchain) are early indicators of multi-cycle roll-up. Founders considering exit should engage in 12-24 months before regulatory transition stabilises (est. 2027-2028) to capture current premium pricing environment.

How CT Acquisitions runs Australia home care sale mandates

CT Acquisitions is a US sell-side advisor with active cross-border M&A deal flow into Australia. Our practice connects Australia owners to: (a) the named Australia PE platforms documented above with active deal posture in your size band and sub-vertical; (b) cross-border US strategic acquirers running an international rollup thesis in your vertical; (c) UK / European PE platforms (Apax, Cinven, EQT, Bridgepoint, Hg, Inflexion, CVC, Permira, BC Partners, Hellman & Friedman, Carlyle, KKR, etc.) running cross-border platforms. The introductory conversation is confidential, NDA-protected, and walks through the band-specific buyer pool, the regulator-transfer timeline at Australian Taxation Office (ATO), and the tax-arbitrage structuring that determines your net-of-tax proceeds.

Frequently asked questions: selling Australia home care businesses in 2026

What multiple should I expect for my Australia home care business in 2026?

Multiples band, premium drivers, and discount drivers are set out in the named-buyer + multiples sections above. The headline answer: most owner-operator sub-A$2M EBITDA businesses trade 3-5x SDE; mid-market A$2-5M EBITDA businesses trade 4-7x EBITDA; platform-candidate A$5-15M EBITDA businesses trade 6-9x; add-ons to a PE platform or public strategic trade 7-11x; and A$50M+ EBITDA strategic transactions reach 9-14x depending on sub-vertical and recurring-revenue mix. The actual band for your business depends on the premium/discount drivers documented in the multiples section above.

Which PE platforms and strategic acquirers are actively acquiring Australia home care businesses in 2026?

The named-buyers section above lists the 3-5 most-active acquirers in Australia for home care as of mid-2026, with ownership, HQ, recent acquisitions, and approximate revenue band documented per buyer. The Australia buyer pool typically includes (a) Australia-domiciled PE platforms; (b) cross-border US or UK strategics running international rollup theses; (c) listed-company strategics on Australian Securities Exchange (ASX); and (d) the global PE platforms (Apax, Cinven, EQT, Bridgepoint, etc.) running cross-border platforms.

How does the Australian Taxation Office (ATO) regulator-transfer procedure affect my sale timeline?

The regulator-transfer procedure section above documents the specific consents, novations, or new-entity applications required for a Australia home care sale. Typical timeline is 60-180 days for most industry licences; some specialised regulators (financial-services AFSL transfers, healthcare CQC/HIQA/HSE notifications, environmental EPA permits) can run 6-12 months. Pre-sale engagement with the regulator 12-18 months before LOI removes most timing risk and is the highest-ROI pre-sale workstream.

What tax-arbitrage structuring is available to Australia home care sellers in 2026?

The tax-arbitrage structuring section above documents the Australia-specific levers available. For most owner-operators with 15+ year holds, the jurisdiction-specific tax relief framework can reduce effective CGT on a multi-million sale to a small fraction of headline gain. The specific arbitrage depends on: (a) ownership tenure (15+ year holds unlock the most powerful exemptions); (b) seller age (some reliefs are age-gated at 55+); (c) entity structure (share sale vs asset sale, individual vs corporate seller, holdco vs trading-company structure); (d) post-completion plans (rollover into replacement asset; super contribution; retirement). Pre-sale tax-structuring engagement with a Australia-domiciled adviser is the single highest-ROI pre-sale workstream after regulator-transfer planning.

What recent 2024-2026 dated comparable transactions in Australia home care should I know about?

The recent-transactions section above lists the 1-3 most-relevant dated comparable transactions in Australia home care from 2024-2026 with named buyer, named target, approximate consideration where disclosed, and source citations. These transactions anchor the multiples band that buyers will reference when underwriting your sale and are the single most-cited piece of evidence in any sell-side IM.

Does CT Acquisitions advise on cross-border M&A from Australia?

Yes — CT Acquisitions is a US sell-side advisor with active cross-border deal flow into Australia. The introductory conversation maps your trailing-12-month revenue and EBITDA in A$ AUD to the band-specific buyer pool, identifies the 18-24 month pre-sale workstream priorities specific to Australia home care, walks through the named buyers actively acquiring in Australia at your size band, and pre-positions the tax-arbitrage outcome that determines your net-of-tax proceeds.

CT ACQUISITIONS

Disclaimer: CT Acquisitions is not a registered broker-dealer, investment advisor, or financial service provider. We act solely as a buy-side consultant and independent sponsor source. All information provided on this website is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or investment opportunity. We do not provide legal, tax, or accounting advice. Any potential transaction is subject to due diligence and legal documentation.

© 2025 CT Acquisitions. All Rights Reserved.